Celebrating India’s independence, enterprise and progress
news

Tianlong Showcases Innovation at Prestigious International Biomedical Forum in Kazakhstan

Apr 22, 2025 · Source: cision
Tianlong Showcases Innovation at Prestigious International Biomedical Forum in Kazakhstan

KARAGANDA, Kazakhstan, April 22, 2025 -- Tianlong Science and Technology is honored to have been invited to speak at the "International Biomedical Forum: Researches and Innovations", held on April 17–18, 2025, at Karaganda Medical University in Kazakhstan. In addition to presenting at the forum, the Tianlong team also conducted site visits and market research activities in Kazakhstan, further deepening engagement with the local healthcare community.

Co-organized by the Ministry of Health of the Republic of Kazakhstan, the Ministry of Science and Higher Education of the Republic of Kazakhstan, and Karaganda Medical University, this high-level event brought together leading voices from the global biomedical community to discuss cutting-edge research and emerging technologies shaping the future of healthcare.

Representing the innovation strength of our group, Jessica Wu, PhD in Biology and Product Manager of Tianlong, delivered a presentation titled "LigSeq Reagent Kits: Personalized Medication for Better Healthcare". The presentation introduced our latest achievements in precision diagnostics, highlighting how LigSeq technology is supporting more individualized and effective treatment pathways.

We were also proud to share the stage with a distinguished lineup of international experts who offered deep insights into the latest biomedical breakthroughs. Among them were Prof. Luc van der Laan from Erasmus University Medical Center in the Netherlands, and Prof. Florent Dumont of Paris-Saclay University. The forum also featured remarks from Mr. Xavier Le Torrivellec, Education Cooperation Attaché of the French Embassy in Kazakhstan, highlighting international collaboration in biomedical education and research.

The forum's agenda reflected its global vision, covering key topics such as drug development, genomics and proteomics, artificial intelligence in healthcare, and the integration of big data in clinical decision-making. Our participation in this prestigious forum underscores Tianlong's ongoing commitment to advancing global healthcare through innovation, collaboration, and expertise.

Following the successful presentation at the forum, the Tianlong team also visited local healthcare institutions and the Research and Production Center of Transfusion under the Ministry of Health of the Republic of Kazakhstan. During these visits, our team held in-depth exchanges with local medical professionals, discussing current trends and needs in blood screening and transfusion safety.

The visit also included a focused market survey on Kazakhstan's blood screening landscape, enabling our team to gain valuable insights into clinical workflows, diagnostic requirements, and regulatory practices in the country. These findings will serve as a crucial foundation for the future introduction and localization of Tianlong's blood screening solutions.

By engaging directly with local professionals and understanding the Kazakhstani diagnostic market, Tianlong continues to lay the groundwork for meaningful contributions to public health initiatives in Central Asia.

About Tianlong

Tianlong Science and Technology, founded in 1997, is a pioneer in the field of genetic testing and molecular diagnostics. Together with our group company Shanghai Kehua Bio-engineering Co., Ltd. (KHB), we have established five core technology platforms — immunodiagnostics, biochemistry, molecular diagnostics, POCT, and mass spectrometry, specializing in the research, development, and manufacturing of instruments and in vitro diagnostic (IVD) reagents — offering comprehensive solutions across a wide range of sectors, including clinical diagnostics, blood centers, disease control, veterinary epidemic prevention, and food safety.

For more information, please visit Tianlong's official website and its LinkedIn, Facebook, and Twitter pages.

Tianlong Science and Technology

Photo - https://mma.prnewswire.com/media/2669856/a.jpg 

Photo - https://mma.prnewswire.com/media/2669866/b.jpg 

Photo - https://mma.prnewswire.com/media/2669867/c.jpg 

Photo - https://mma.prnewswire.com/media/2669868/d.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/tianlong-showcases-innovation-at-prestigious-international-biomedical-forum-in-kazakhstan-302434415.html

Comments (0)

Login to join the conversation

Login / Register

No comments yet. Be the first to comment!

More to Read

Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research
news
Aug 11, 2026 1 min

Metabolon Launches Peak Science Grant Program to Advance Breakthrough Metabolomics Research

Quarterly grant program provides researchers with no-cost access to Metabolon s industry-leading metabolomics platform, scientific expertise, bioinformatics tools, and data interpretation resources MORRISVILLE, N.C. , Aug. 11, 2026 -- Metabolon, Inc., the global leader in metabolomics solutions advancing life sciences research, diagnostic, therapeutic, and precision medicine applications, today announced the launch of the Metabolon Peak Science Grant Program, a competitive quarterly grant designed to help researchers advance high-impact science through access to Metabolon s industry-leading metabolomics platform, analytical services, bioinformatics tools, data resources, and scientific expertise.

NYSE Content Update: Lumilens Tops $5.5 Billion Valuation After Latest Funding
news
Aug 11, 2026 1 min

NYSE Content Update: Lumilens Tops $5.5 Billion Valuation After Latest Funding

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK , Aug. 11, 2026 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today s NYSE Pre-market update for market insights before trading begins. Kristen Scholer delivers the pre-market update on August 11th ICE Brent Crude approaches 90 a barrel as investors navigate the latest uncertainties in the Middle East. Lumilens CMO Mark Weiner will join NYSE Live to discuss how the AI infrastructure connectivity platform will capitalize on fresh funding. Announced Series C raise of more than 700 earlier this month. Latest funding brought its capital raised to over 900 million. JERi co-founders Ross Yellowlees and Emily Ward will join NYSE Live to explain how their new platform is designed to disrupt the status quo.

Blockchain for Good Alliance and Bybit Join the Mauritius Internet Governance Forum to Advance Digital Trust for Small Island States
news
Aug 11, 2026 1 min

Blockchain for Good Alliance and Bybit Join the Mauritius Internet Governance Forum to Advance Digital Trust for Small Island States

DUBAI, UAE , Aug. 11, 2026 -- Blockchain for Good Alliance (BGA) , the global non-profit initiative founded by Bybit, dedicated to leveraging blockchain for societal impact, took part in the Mauritius Internet Governance Forum, founded by the Halley Movement, contributing perspectives on how blockchain and emerging technologies can support an inclusive, secure, and trustworthy digital future for small island developing states (SIDS). The Mauritius Internet Governance Forum, recognised by the United Nations IGF Secretariat as a national IGF, convenes government, industry, academia, civil society, and youth in multistakeholder dialogue on the future of internet governance. This year s engagement centred on the themes of artificial intelligence, cybersecurity, and digital trust.

Green Cabbage Announces the Launch of the F&I (Finance & Insurance) Market Data Spend Cube
news
Aug 11, 2026 1 min

Green Cabbage Announces the Launch of the F&I (Finance & Insurance) Market Data Spend Cube

New Spend Cube Enables Global Companies to Negotiate Smarter Deals with F&I Suppliers PITTSBURGH , Aug. 11, 2026 -- Green Cabbage, the leading procurement intelligence partner for 2,600+ organizations across North America, EMEA, APAC, and LATAM, today announced the launch of its F&I (Finance & Insurance) Market Data Spend Cube. The F&I Spend Cube arms finance, procurement, and legal teams with independent market intelligence to identify spending patterns, eliminate overpayment, and unlock negotiation leverage across three critical spend categories: Market Data & Information Aggregators, Insurance & Financial Services Technology, and Financial Services Operations & Analytics.

IBM and Together AI Sign Multi-Year Agreement to Scale Open-Source AI Inference with NVIDIA AI Infrastructure on IBM Cloud
news
Aug 11, 2026 1 min

IBM and Together AI Sign Multi-Year Agreement to Scale Open-Source AI Inference with NVIDIA AI Infrastructure on IBM Cloud

First large-scale inference cluster with Together AI on IBM Cloud using NVIDIA HGX B300 systems to help enterprises run AI workloads, designed for fast and efficient production ARMONK, N.Y. and SAN FRANCISCO , Aug. 11, 2026 -- IBM (NYSE: IBM ) announced a collaboration with Together AI to deliver IBM and NVIDIA AI infrastructure. Under a multi-year 240M agreement between IBM and Together AI, IBM is positioned to deploy a large cluster of NVIDIA HGX B300 systems on IBM Cloud with expected availability in Q1 2027. Together AI will use this cluster to provide open-source model inference. This deployment is the first dedicated, large-scale cluster built for inference on IBM Cloud using HGX B300 systems and NVIDIA Spectrum - X TM Ethernet networking. According to NVIDIA, it is built to deliver 30x more AI factory output compared to prior generations.

Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
news
Aug 11, 2026 1 min

Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect®, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging

VueJect strengthens Bracco s integrated CEUS ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging MILAN , Aug. 11, 2026 -- Bracco Imaging today announced that VueJect , its first dedicated ultrasound contrast delivery system engineered to support cardiology imaging specifically, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and authorization from Health Canada. These regulatory milestones represent the first step in Bracco s broader global commercialization strategy for VueJect, reinforcing the company s long-term commitment to advancing contrast-enhanced ultrasound (CEUS). VueJect will initially be available in the United States and Canada, with additional regulatory submissions planned in other markets.

AI's Growth Reveals a Hidden $4.63 Trillion Problem: Outdated and Unmanaged Enterprise Content
news
Aug 11, 2026 1 min

AI's Growth Reveals a Hidden $4.63 Trillion Problem: Outdated and Unmanaged Enterprise Content

The cost of content debt is greater than the GDP of Japan, the fourth-largest economy in the world NEW YORK , Aug. 11, 2026 -- New research from Storyblok , in collaboration with FT Longitude (part of The Financial Times), uncovers the true cost of content debt: content that is outdated, poorly structured, not optimized for search or AI discovery, and difficult to update and publish efficiently. According to a survey of organizations with at least 1 billion in annual global revenue, content debt is costing enterprises 4.63 trillion worldwide, based on spend devoted to fixing it and revenue at risk from it.

9Spokes Launches Pulse: Configurable Data & Insights for SMB Customers of Financial Service Providers
news
Aug 11, 2026 1 min

9Spokes Launches Pulse: Configurable Data & Insights for SMB Customers of Financial Service Providers

AUCKLAND, New Zealand , Aug. 11, 2026 -- 9Spokes , a leading global data platform, announced the launch of Pulse , a new intelligence layer within its SMB Financial Hub platform that delivers small business customers answers they cannot get from their bank app, accounting software, or merchant terminal alone. With AI raising the bar for how people expect to consume data, SMB owners now want plain-language answers, not static dashboards they want insights that explain what their data means and what to do about it. Pulse is built for that shift and for financial service providers who are not yet ready to implement customer-facing AI solutions but who recognize the shift.